Pharmafile Logo
Pharmafocus logo
Advanced Search

oncology

Showing 15 posts of 301 posts found.

Cobra biologics image

Cobra agrees oncology deal with BioCancell

March 4, 2014
Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology

Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …

News
Abbvie image

AbbVie expands into Singapore

February 10, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology

AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …

News
Abbvie image

AbbVie advances oncology drug

January 21, 2014
Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer.  This …

News
Astrazeneca image

AstraZeneca strikes cancer vaccine pact

January 8, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, oncology

AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …

News
Bayer image

Bayer in $2.9 billion Algeta deal

December 19, 2013
Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer and Algeta have decided to avoid the usual M&A dance, opting instead to agree a business deal with little …

News
gsk image

GSK launches cancer ‘consortium’

December 6, 2013
Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research

GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …

News

Bayer targets Norway’s Algeta

November 27, 2013
Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer HealthCare is in the market to buy Norwegian oncology specialist Algeta. The German pharma group has made a bid …

News
Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature

Boehringer and Ventana link up

September 24, 2013
Research and Development, Sales and Marketing Boehringer, Ventana, oncology

Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …

News
Bayer image

Bayer partners with US academics

September 13, 2013
Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …

News
claire_thom_astellas

Astellas hires senior VP from rival Takeda

August 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …

Appointment
pfizerworld

Pfizer abandons cancer trial

May 22, 2013
Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …

News
Roche image

Swiss Re helps Roche open up China’s oncology market

December 17, 2012
Sales and Marketing Cancer, China, Roche, Swiss re, oncology

Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …

News
novartis_window

Novartis blood cancer hope

December 12, 2012
Research and Development, Sales and Marketing Jakavi, Novartis, oncology

Two-year data from Novartis’s drug Jakavi suggests that it may improve overall survival in a rare form of cancer versus …

News
lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012
Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024